Text Size

Association of the Intrarenal Resistance Index (RI) of Transplanted Kidneys With Generalized Atherosclerosis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2010 by University of Zurich.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University of Zurich
ClinicalTrials.gov Identifier:
NCT01001065
First received: October 22, 2009
Last updated: June 28, 2010
Last verified: June 2010
History of Changes
  Purpose

Cross sectional observational ultrasound study of transplanted kidneys and the carotid artery in consecutive recruited outpatients.


Condition Intervention
Renal Transplantation
 Procedure: Vascular ultrasound

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:

MedlinePlus related topics: Atherosclerosis
U.S. FDA Resources

Further study details as provided by University of Zurich:

Estimated Enrollment: 160
Study Start Date: October 2009
Estimated Study Completion Date: October 2010
Intervention Details:
    Procedure: Vascular ultrasound
    RI ist predictive for arteriosclerosis
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients after renal transplantation with stable renal function

Criteria

Inclusion criteria:

  • Patients after renal transplantation with stable renal function

Exclusion criteria:

  • Known impairment of renal function (e.g. acute rejection)
  • Known renal artery or carotid artery stenosis
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01001065

Contacts
Contact: 01 Studienregister MasterAdmins +41 (0)44 255 11 11

Locations
Switzerland
Recruiting
Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
Investigators
Study Director: 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich
  More Information

No publications provided

Responsible Party: Christoph Thalhammer, MD, USZ
ClinicalTrials.gov Identifier: NCT01001065     History of Changes
Other Study ID Numbers: CT-03-2009-USZ
Study First Received: October 22, 2009
Last Updated: June 28, 2010
Health Authority: Switzerland: Ethikkommission

ClinicalTrials.gov processed this record on June 18, 2013